Correlation Between Equillium and Vor Biopharma

Can any of the company-specific risk be diversified away by investing in both Equillium and Vor Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Equillium and Vor Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Equillium and Vor Biopharma, you can compare the effects of market volatilities on Equillium and Vor Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Equillium with a short position of Vor Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Equillium and Vor Biopharma.

Diversification Opportunities for Equillium and Vor Biopharma

-0.47

Correlation Coefficient

Equillium  Vor Biopharma

Very good diversification

The 3 months correlation between Equillium and Vor is -0.47. Overlapping area represents the amount of risk that can be diversified away by holding Equillium and Vor Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vor Biopharma and Equillium is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Equillium are associated (or correlated) with Vor Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vor Biopharma has no effect on the direction of Equillium i.e., Equillium and Vor Biopharma go up and down completely randomly.

Pair Corralation between Equillium and Vor Biopharma

Allowing for the 90-day total investment horizon Equillium is expected to under-perform the Vor Biopharma. In addition to that, Equillium is 1.4 times more volatile than Vor Biopharma. It trades about -0.02 of its total potential returns per unit of risk. Vor Biopharma is currently generating about 0.06 per unit of volatility. If you would invest  76.00  in Vor Biopharma on September 25, 2024 and sell it today you would earn a total of  11.00  from holding Vor Biopharma or generate 14.47% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Equillium  vs.  Vor Biopharma

Equillium

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Equillium has generated negative risk-adjusted returns adding no value to investors with long positions. Even with latest unsteady performance, the Stock's basic indicators remain invariable and the latest agitation on Wall Street may also be a sign of long-running gains for the enterprise retail investors.

Vor Biopharma

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Vor Biopharma are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Even with relatively conflicting basic indicators, Vor Biopharma reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Equillium and Vor Biopharma

The main advantage of trading using opposite Equillium and Vor Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Equillium position performs unexpectedly, Vor Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vor Biopharma will offset losses from the drop in Vor Biopharma's long position.

The idea behind Equillium and Vor Biopharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.